{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,30]],"date-time":"2026-06-30T23:33:18Z","timestamp":1782862398169,"version":"3.54.5"},"reference-count":29,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","thrombosisresearch.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Thrombosis Research"],"published-print":{"date-parts":[[2022,10]]},"DOI":"10.1016\/j.thromres.2022.08.004","type":"journal-article","created":{"date-parts":[[2022,8,11]],"date-time":"2022-08-11T11:13:52Z","timestamp":1660216432000},"page":"17-23","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"special_numbering":"C","title":["Antiphospholipid syndrome: Reversal of antiphosphatidylserine\/prothrombin-induced activated protein C resistance"],"prefix":"10.1016","volume":"218","author":[{"given":"Elena","family":"Pontara","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Grazia","family":"Cattini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elisa","family":"Bison","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chunyan","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gentian","family":"Denas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vittorio","family":"Pengo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.thromres.2022.08.004_bb0005","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1111\/j.1538-7836.2006.01753.x","article-title":"International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS)","volume":"4","author":"Miyakis","year":"2006","journal-title":"J. Thromb. Haemost."},{"key":"10.1016\/j.thromres.2022.08.004_bb0010","article-title":"Interaction between antiphospholipid antibodies and protein C anticoagulant pathway: a narrative review","author":"Pengo","year":"2022","journal-title":"Semin. Thromb. Hemost."},{"key":"10.1016\/j.thromres.2022.08.004_bb0015","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1111\/j.1538-7836.2009.03674.x","article-title":"Clinical course of high-risk patients diagnosed with antiphospholipid syndrome","volume":"8","author":"Pengo","year":"2010","journal-title":"J. Thromb. Haemost."},{"key":"10.1016\/j.thromres.2022.08.004_bb0020","doi-asserted-by":"crossref","first-page":"4714","DOI":"10.1182\/blood-2011-03-340232","article-title":"Incidence of a first thromboembolic event in asymptomatic carriers of high-risk antiphospholipid antibody profile: a multicenter prospective study","volume":"118","author":"Pengo","year":"2011","journal-title":"Blood"},{"key":"10.1016\/j.thromres.2022.08.004_bb0025","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1160\/TH06-05-0287","article-title":"Antibody profile and clinical course in primary antiphospholipid syndrome with pregnancy morbidity","volume":"96","author":"Ruffatti","year":"2006","journal-title":"Thromb. Haemost."},{"key":"10.1016\/j.thromres.2022.08.004_bb0030","doi-asserted-by":"crossref","first-page":"1124","DOI":"10.1111\/jth.14765","article-title":"Tetra positive thrombotic antiphospholipid syndrome: major contribution of anti phosphatidyl-serine\/prothrombin antibodies to lupus anticoagulant activity","volume":"18","author":"Cattini","year":"2020","journal-title":"J. Thromb. Haemost."},{"key":"10.1016\/j.thromres.2022.08.004_bb0035","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1111\/jth.15199","article-title":"Insight into the hypercoagulable state of high-risk thrombotic APS patients: contribution of abeta2GPI and aPS\/PT antibodies","volume":"19","author":"Pontara","year":"2021","journal-title":"J. Thromb. Haemost."},{"key":"10.1016\/j.thromres.2022.08.004_bb0040","doi-asserted-by":"crossref","first-page":"1365","DOI":"10.1182\/blood-2018-04-848333","article-title":"Rivaroxaban vs warfarin in high-risk patients with antiphospholipid syndrome","volume":"132","author":"Pengo","year":"2018","journal-title":"Blood"},{"key":"10.1016\/j.thromres.2022.08.004_bb0045","doi-asserted-by":"crossref","first-page":"1737","DOI":"10.1111\/j.1538-7836.2009.03555.x","article-title":"Update of the guidelines for lupus anticoagulant detection","volume":"7","author":"Pengo","year":"2009","journal-title":"J. Thromb. Haemost."},{"key":"10.1016\/j.thromres.2022.08.004_bb0050","doi-asserted-by":"crossref","first-page":"2828","DOI":"10.1111\/jth.15047","article-title":"Guidance from the scientific and standardization committee for lupus anticoagulant\/antiphospholipid antibodies of the international society on thrombosis and haemostasis: update of the guidelines for lupus anticoagulant detection and interpretation","volume":"18","author":"Devreese","year":"2020","journal-title":"J. Thromb. Haemost."},{"key":"10.1016\/j.thromres.2022.08.004_bb0055","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1111\/jth.13976","article-title":"Subcommittee on lupus anticoagulant\/antiphospholipid A: laboratory criteria for antiphospholipid syndrome: communication from the SSC of the ISTH","volume":"16","author":"Devreese","year":"2018","journal-title":"J. Thromb. Haemost."},{"key":"10.1016\/j.thromres.2022.08.004_bb0060","doi-asserted-by":"crossref","first-page":"1608","DOI":"10.1373\/49.10.1608","article-title":"Lupus anticoagulant (LA) testing: performance of clinical laboratories assessed by a national survey using lyophilized affinity-purified immunoglobulin with LA activity","volume":"49","author":"Tripodi","year":"2003","journal-title":"Clin. Chem."},{"key":"10.1016\/j.thromres.2022.08.004_bb0065","doi-asserted-by":"crossref","first-page":"1372","DOI":"10.1111\/jth.15287","article-title":"Recommendations for the measurement of thrombin generation: communication from the ISTH SSC subcommittee on lupus anticoagulant\/antiphospholipid antibodies","volume":"19","author":"Ninivaggi","year":"2021","journal-title":"J. Thromb. Haemost."},{"key":"10.1016\/j.thromres.2022.08.004_bb0070","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1046\/j.1365-2141.1999.01596.x","article-title":"Lipid composition of seven APTT reagents in relation to heparin sensitivity","volume":"106","author":"Kitchen","year":"1999","journal-title":"Br. J. Haematol."},{"key":"10.1016\/j.thromres.2022.08.004_bb0075","doi-asserted-by":"crossref","first-page":"2426","DOI":"10.1182\/blood.V74.7.2426.2426","article-title":"Impaired catalytic function of activated protein C: a new in vitro manifestation of lupus anticoagulant","volume":"74","author":"Marciniak","year":"1989","journal-title":"Blood"},{"key":"10.1016\/j.thromres.2022.08.004_bb0080","doi-asserted-by":"crossref","first-page":"1584","DOI":"10.1073\/pnas.80.6.1584","article-title":"Human coagulation factor va is a cofactor for the activation of protein C","volume":"80","author":"Salem","year":"1983","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.thromres.2022.08.004_bb0085","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1111\/j.1365-2141.1990.tb07843.x","article-title":"Inhibition of activated protein C and its cofactor protein S by antiphospholipid antibodies","volume":"76","author":"Malia","year":"1990","journal-title":"Br. J. Haematol."},{"key":"10.1016\/j.thromres.2022.08.004_bb0090","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1111\/j.1365-2141.1990.tb06372.x","article-title":"Studies of natural anticoagulant proteins and anticardiolipin antibodies in patients with the lupus anticoagulant","volume":"76","author":"Lo","year":"1990","journal-title":"Br. J. Haematol."},{"key":"10.1016\/j.thromres.2022.08.004_bb0095","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1097\/00001721-199402000-00006","article-title":"A new variant of interaction between phospholipid antibodies and the protein C system","volume":"5","author":"Bokarewa","year":"1994","journal-title":"Blood Coagul. Fibrinolysis"},{"key":"10.1016\/j.thromres.2022.08.004_bb0100","doi-asserted-by":"crossref","first-page":"1132","DOI":"10.1055\/s-0037-1614192","article-title":"Dependence on prothrombin for inhibition of activated protein C activity by lupus antibodies","volume":"84","author":"Field","year":"2000","journal-title":"Thromb. Haemost."},{"key":"10.1016\/j.thromres.2022.08.004_bb0105","doi-asserted-by":"crossref","first-page":"1999","DOI":"10.1182\/blood.V91.6.1999","article-title":"Differential effects of anti-beta2-glycoprotein I and antiprothrombin antibodies on the anticoagulant activity of activated protein C","volume":"91","author":"Galli","year":"1998","journal-title":"Blood"},{"key":"10.1016\/j.thromres.2022.08.004_bb0110","first-page":"699","article-title":"The presence of anti-phosphatidylserine\/prothrombin antibodies as risk factor for both arterial and venous thrombosis in patients with systemic lupus erythematosus","volume":"91","author":"Nojima","year":"2006","journal-title":"Haematologica"},{"key":"10.1016\/j.thromres.2022.08.004_bb0115","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1097\/00001721-199604000-00009","article-title":"Activated protein C resistance phenotype and genotype in patients with primary antiphospholipid syndrome","volume":"7","author":"Ruiz-Arguelles","year":"1996","journal-title":"Blood Coagul. Fibrinolysis"},{"key":"10.1016\/j.thromres.2022.08.004_bb0120","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/0049-3848(90)90324-6","article-title":"Impairment of the protein C anticoagulant pathway in a patient with systemic lupus erythematosus, anticardiolipin antibodies and thrombosis","volume":"57","author":"Amer","year":"1990","journal-title":"Thromb. Res."},{"key":"10.1016\/j.thromres.2022.08.004_bb0125","doi-asserted-by":"crossref","first-page":"100788","DOI":"10.1016\/j.blre.2020.100788","article-title":"Arterial thrombosis in antiphospholipid syndrome (APS): Clinical approach and treatment. A systematic review","volume":"48","author":"Cheng","year":"2021","journal-title":"Blood Rev."},{"key":"10.1016\/j.thromres.2022.08.004_bb0130","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1182\/blood.V94.3.895.415k01_895_901","article-title":"Extensive venous and arterial thrombosis associated with an inhibitor to activated protein C","volume":"94","author":"Zivelin","year":"1999","journal-title":"Blood"},{"key":"10.1016\/j.thromres.2022.08.004_bb0135","doi-asserted-by":"crossref","first-page":"1659","DOI":"10.1161\/CIRCULATIONAHA.108.780759","article-title":"Hereditary deficiency of protein C or protein S confers increased risk of arterial thromboembolic events at a young age: results from a large family cohort study","volume":"118","author":"Mahmoodi","year":"2008","journal-title":"Circulation"},{"key":"10.1016\/j.thromres.2022.08.004_bb0140","article-title":"Protein C deficiency as a risk factor for stroke in young adults: a review","volume":"12","author":"Majid","year":"2020","journal-title":"Cureus"},{"key":"10.1016\/j.thromres.2022.08.004_bb0145","doi-asserted-by":"crossref","first-page":"3275","DOI":"10.1161\/STROKEAHA.113.000736","article-title":"Brain regulation of thrombosis and hemostasis: from theory to practice","volume":"44","author":"Fisher","year":"2013","journal-title":"Stroke"}],"container-title":["Thrombosis Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0049384822003371?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0049384822003371?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,24]],"date-time":"2025-09-24T17:49:04Z","timestamp":1758736144000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0049384822003371"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,10]]},"references-count":29,"alternative-id":["S0049384822003371"],"URL":"https:\/\/doi.org\/10.1016\/j.thromres.2022.08.004","relation":{},"ISSN":["0049-3848"],"issn-type":[{"value":"0049-3848","type":"print"}],"subject":[],"published":{"date-parts":[[2022,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Antiphospholipid syndrome: Reversal of antiphosphatidylserine\/prothrombin-induced activated protein C resistance","name":"articletitle","label":"Article Title"},{"value":"Thrombosis Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.thromres.2022.08.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}